Seoulin Bioscience Co.Ltd (038070) — Free Cash Flow Generation Index
Seoulin Bioscience Co.Ltd (038070) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of ₩620.87 Million represents 1% of operating cash flow (₩631.76 Million). Explore 038070 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Seoulin Bioscience Co.Ltd Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Seoulin Bioscience Co.Ltd across 11 annual periods. For the full cash flow conversion analysis, see Seoulin Bioscience Co.Ltd (038070) cash flow conversion.
Annual Free Cash Flow Generation for Seoulin Bioscience Co.Ltd (2013–2025)
Year-by-year Free Cash Flow Generation Index for Seoulin Bioscience Co.Ltd. Check total reinvestment intensity of Seoulin Bioscience Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | ₩4.25 Billion | ₩4.76 Billion | ₩507.47 Million | ▲ +2004.7% |
| 2023 | -0.05x | ₩-43.65 Million | ₩930.57 Million | ₩974.21 Million | ▼ -105.8% |
| 2021 | 0.81x | ₩7.25 Billion | ₩8.92 Billion | ₩1.67 Billion | ▲ +9.2% |
| 2020 | 0.74x | ₩2.74 Billion | ₩3.68 Billion | ₩401.34 Million | ▼ -28.2% |
| 2019 | 1.04x | ₩7.59 Billion | ₩7.32 Billion | ₩269.29 Million | ▼ -5.6% |
| 2018 | 1.10x | ₩4.58 Billion | ₩4.17 Billion | ₩408.02 Million | ▼ -85.8% |
| 2017 | 7.71x | ₩10.03 Billion | ₩1.30 Billion | ₩8.73 Billion | ▲ +113.0% |
| 2016 | 3.62x | ₩9.97 Billion | ₩2.76 Billion | ₩7.21 Billion | ▲ +89.5% |
| 2015 | 1.91x | ₩7.86 Billion | ₩4.12 Billion | ₩3.74 Billion | ▲ +49.4% |
| 2014 | 1.28x | ₩3.50 Billion | ₩2.74 Billion | ₩761.57 Million | ▲ +26.4% |
| 2013 | 1.01x | ₩4.99 Billion | ₩4.94 Billion | ₩55.65 Million | — |